Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-12
1996-01-16
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514885, 514974, 548204, C07D27730, A61K 31425, A01N 4378
Patent
active
054848016
ABSTRACT:
A pharmaceutical composition is disclosed which comprises a solution of an HIV protease inhibiting compound in a pharmaceutically acceptable organic solvent comprising a mixture of (1) (a) a solvent selected from propylene glycol and polyethylene glycol or (b) a solvent selected from polyoxyethyleneglycerol triricinoleate, polyethylene glycol 40 hydrogenated castor oil, fractionated coconut oil, polyoxyethylene (20) sorbitan monooleate and 2-(2-ethoxyethoxy)ethanol or (c) a mixture thereof and (2) ethanol or propylene glycol.
REFERENCES:
patent: 5086165 (1992-02-01), Marshall et al.
patent: 5164300 (1992-11-01), Marshall et al.
patent: 5171662 (1992-12-01), Sharma
patent: 5183826 (1993-02-01), Bills et al.
patent: 5250563 (1993-10-01), Chen et al.
patent: 5256677 (1993-10-01), Sham et al.
patent: 5296604 (1994-03-01), Hanko et al.
patent: 5342922 (1994-08-01), Marshall et al.
patent: 5354866 (1994-10-01), Kempf et al.
Al-Razzak Laman A.
Kaul Dilip
Manning Lourdes P.
Marsh Kennan C.
Abbott Laboratories
Crowley Steven R.
Griffin Ronald W.
LandOfFree
Pharmaceutical composition for inhibiting HIV protease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for inhibiting HIV protease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for inhibiting HIV protease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-309635